Paper
Cytotoxic activities of substituted 3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones and studies on their mechanisms of action.
Published Jun 1, 2013 · A. Andreani, M. Granaiola, A. Locatelli
European journal of medicinal chemistry
Q2 SJR score
15
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
In Vitro StudyStudy Snapshot
Substituted trimethoxybenzylidene-indolinones show cytotoxic activity against cancer cells, with some showing antiproliferative effects by inhibiting Nox4 and tubulin assembly.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
NADPH Oxidase Subunit 4-Mediated Reactive Oxygen Species Contribute to Cycling Hypoxia-Promoted Tumor Progression in Glioblastoma Multiforme
Cycling hypoxia-induced reactive oxygen species via Nox4 contributes to tumor progression in glioblastoma multiforme, and targeting this pathway may help treat the disease.
2011·116citations·C. Hsieh et al.·PLoS ONE
PLoS ONE
NADPH Oxidase 4 Promotes Endothelial Angiogenesis Through Endothelial Nitric Oxide Synthase Activation
Overexpression of NADPH oxidase 4 in endothelium promotes angiogenesis and recovery from hypoxia through increased eNOS activity.
2011·258citations·Siobhan M. Craige et al.·Circulation
Circulation
Piper sarmentosum inhibits ICAM-1 and Nox4 gene expression in oxidative stress-induced human umbilical vein endothelial cells
Piper sarmentosum extract suppresses ICAM-1 and Nox4 gene expression and inducing antioxidant enzymes, potentially contributing to its vascular protective effect.
2011·49citations·A. Ugusman et al.·BMC Complementary and Alternative Medicine
BMC Complementary and Alternative Medicine
Small-molecule inhibitors of NADPH oxidase 4.
Novel NOX4 inhibitors were identified, with three selected for further drug development, potentially benefiting oxidative damage-related diseases.
2010·55citations·G. Borbély et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
NADPH oxidase 4 is an oncoprotein localized to mitochondria
NOX4 protein, found in breast cancer cells and ovarian tumors, plays an oncogenic role and generates reactive oxygen species, which may be treated with antioxidant treatment.
2010·215citations·K. Graham et al.·Cancer Biology & Therapy
Cancer Biology & Therapy
Citations
Alkenyl oxindole is a novel PROTAC moiety that recruits the CRL4DCAF11 E3 ubiquitin ligase complex for targeted protein degradation
Alkenyl oxindole conjugates with bromodomain-containing protein 4 inhibitor JQ1 show potential for targeted protein degradation and antitumor activity, offering new possibilities for drug discovery.
2024·5citations·Ying Wang et al.·PLOS Biology
PLOS Biology
Structural Optimization, Anti‐TNBC Activities Evaluation, and Molecular Docking of an Indolone Derivative from Periplaneta americana
LJ23, a novel indolone derivative from Periplaneta americana, shows promising antitumor activity against triple-negative breast cancer by inhibiting cell motility and downregulating the EMT process.
2024·0citations·Qin‐Bin Jiang et al.·ChemistrySelect
ChemistrySelect
Vanillin-Based Indolin-2-one Derivative Bearing a Pyridyl Moiety as a Promising Anti-Breast Cancer Agent via Anti-Estrogenic Activity
The indolin-2-one derivative 6j shows promising anti-breast cancer activity by inhibiting estrogenic activity, making it a promising lead compound for further pharmaceutical formulations.
2023·23citations·O. Bender et al.·ACS Omega
ACS Omega
Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation
Oxidole-based FLT3 inhibitors show potential as a selective and effective therapeutic lead for acute myeloid leukemia with the oncogenic ITD mutation.
2022·17citations·O. Bender et al.·Archiv der Pharmazie
Archiv der Pharmazie
Discovery and Anticancer Activity of Novel 1,3,4-Thiadiazole- and Aziridine-Based Indolin-2-ones via In Silico Design Followed by Supramolecular Green Synthesis
Novel 1,3,4-thiadiazole- and aziridine-based indolin-2-ones show potential as potential cancer treatments, with compounds IVc and VIc showing potent activity against breast and colon cancer cell lines.
2022·13citations·P. Chaudhari et al.·ACS Omega
ACS Omega
New Multi-Targeted Antiproliferative Agents: Design and Synthesis of IC261-Based Oxindoles as Potential Tubulin, CK1 and EGFR Inhibitors
IC261-based oxindoles show potential as potent multitarget agents against colon cancer, inhibiting microtubule assembly, CK1, and EGFR-tyrosine kinase, with potential for further optimization.
2021·12citations·Momen R. Fareed et al.·Pharmaceuticals
Pharmaceuticals
Indole derivatives (2010-2020) as versatile tubulin inhibitors: synthesis and structure-activity relationships.
Indole derivatives show potential as versatile tubulin inhibitors for cancer therapy, with synthesis, structure-activity relationships, and biological activities being updated over the past decade.
2021·17citations·Fatima Naaz et al.·Future medicinal chemistry
Future medicinal chemistry
Logical synthetic strategies and structure-activity relationship of indolin-2-one hybrids as small molecule anticancer agents: An Overview
Indolin-2-one hybrids show potential as anticancer agents, with recent progress in synthetic development and structure-activity relationship research.
2021·25citations·P. Chaudhari et al.·Journal of Molecular Structure
Journal of Molecular Structure